Megaclite Pharmaceuticals Private Limited

Megaclite Pharmaceuticals Private Limited - pharma in Gandipet, Telangana, India. Directors, charges & compliance details.
CIN U24239TG2021PTC151090 Incorporated 30 April 2021 ROC Hyderabad HQ Gandipet, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2023
₹1.43 Cr
▲ 23% YoY
Net profit · FY 2023
₹1.4 Lakh
Net margin 1%
EBITDA · FY 2023
₹4.58 Lakh
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹85 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings

About Megaclite Pharmaceuticals Private Limited

Data last updated:

Megaclite Pharmaceuticals Private Limited is a private limited company based in Gandipet, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 April 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2021PTC151090. Its GSTIN is 36AAOCM5622P1ZS (Telangana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shaik Chandini and Begum Sumayya.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H.No 4 – 147/29 Omnagar Colony Kismathpur Near Rock Church, Gandipet, Telangana, India – 500086.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.43 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.4 Lakh (net margin 1%) and EBITDA of ₹4.58 Lakh (EBITDA margin 3.2%).

As per MCA filings, the company has open charges of ₹85 Lakh on record.

Megaclite Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0014085).

Company details

CIN U24239TG2021PTC151090
Registration Number 151090
Incorporation Date 30 April 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0014085
Key People
Shaik Chandini Director Begum Sumayya Director Ranga Rao Yama Director

Recognitions & Rankings of Megaclite Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-TS-09-0014085

Contact details

Megaclite Pharmaceuticals Private Limited's registered office is in Gandipet, Telangana.

  • Registered Address
    H.No 4 – 147/29 Omnagar Colony Kismathpur Near Rock Church, Gandipet, Telangana, India – 500086
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Megaclite Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Megaclite Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Megaclite Pharmaceuticals Private Limited, buy the company report.

Financials of Megaclite Pharmaceuticals Private Limited

FY 2023 filings available

Megaclite Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 23% YoY) for FY 2023.

Revenue · FY 2023
₹1.43 Cr ▲ 23%
Net profit · FY 2023
₹1.4 Lakh margin 1%
EBITDA · FY 2023
₹4.58 Lakh margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
EBITDA CAGR growth
1 year
▲ 104%

Revenue rose 23% in the latest year. EBITDA rose 104% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.58 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.4 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin3.2%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Megaclite Pharmaceuticals Private Limited, buy the company report.

Board of directors of Megaclite Pharmaceuticals Private Limited

Megaclite Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shaik Chandini
Also directs: Terranest Agro Exports Private Limited, RKV Exim Private Limited, Krish Agri Products Private Limited
Director30 Apr 20215 Years 6 MonthsCurrent
Begum SumayyaDirector30 Apr 20215 Years 6 MonthsCurrent
Ranga Rao YamaDirector30 Apr 20215 Years 6 MonthsCurrent
View all directors

Charges & borrowings

Open charges
₹85 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.85 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Dec 2021100532605Bank of India₹85 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Megaclite Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Megaclite Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
36AAOCM5622P1ZSTelanganaActive01 Jun 2021
37AAOCM5622P1ZQAndhra PradeshActive04 Oct 2021

To see the full GST registrations and return filing status of Megaclite Pharmaceuticals Private Limited, buy the company report.

Recent activity

Megaclite Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Begum Sumayya was appointed as Director on 30 Apr 2021.

AGM
Megaclite Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Megaclite Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Charges
A charge with Bank Of India amounted to Rs. 85.00 Lakh with Charge ID 100532605 was registered on 27 Dec 2021.
Appointed
Begum Sumayya was appointed as Director.
Appointed
Ranga Rao Yama was appointed as Director.
Appointed
Shaik Chandini was appointed as Director.
Incorporation
30 Apr 2021
Megaclite Pharmaceuticals Private Limited was registered on 30 Apr 2021 with Roc Hyderabad & aged 5 years 6 months as per MCA records.

Frequently asked questions

Megaclite Pharmaceuticals is an active private limited company based in Gandipet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 April 2021 (5+ years old) and is registered under CIN U24239TG2021PTC151090.

Megaclite Pharmaceuticals has 3 current directors:

The latest financial statements of Megaclite Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Megaclite Pharmaceuticals is 36AAOCM5622P1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAOCM5622P1ZQ (Andhra Pradesh).

The CIN (Corporate Identification Number) of Megaclite Pharmaceuticals is U24239TG2021PTC151090. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Megaclite Pharmaceuticals was incorporated on 30 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

Begum Sumayya was appointed as Director on 30 Apr 2021. Ranga Rao Yama was appointed as Director on 30 Apr 2021. Shaik Chandini was appointed as Director on 30 Apr 2021.

Yes, Megaclite Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0014085).

The registered office of Megaclite Pharmaceuticals is at H.No 4 – 14729 Omnagar Colony Kismathpur Near Rock Church, Gandipet, Telangana, India – 500086.

Megaclite Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.